🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,589 results for “Pharma” Clear

  1. Fezolinetant

    Astellas Pharma Inc

    Hot Flashes

    phase 3 small molecule completed

    1 trial

  2. Fianlimab, LIBTAYO 350 mg concentrate for solution for infusion., Placebo for Fianlimab

    Lacuna Pharma Pty Ltd

    Advanced Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  3. Fingolimod

    Novartis Pharmaceuticals

    Multiple Sclerosis (MS)

    phase 3 small molecule active

    1 trial

  4. Firibastat

    Quantum Biopharma

    Hypertension

    phase 3 small molecule completed

    1 trial

  5. Firibastat (QGC001) Period 1

    Quantum Biopharma

    Hypertension (HTN)

    phase 3 small molecule terminated

    1 trial

  6. Firmonertinib

    ArriVent BioPharma

    Non-Small-Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  7. Firmonertinib

    ArriVent BioPharma

    NSCLC

    phase 3 small molecule active

    1 trial

  8. Flecainide or Sotalol or Propafenone

    Rhythm Pharmaceuticals Netherlands B.V.

    Paroxysmal Atrial Fibrillation

    phase 3 small molecule completed

    1 trial

  9. Flucelvax Tetra - suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell cultures), PNEUMOVAX solution injectable en flacon Vaccin pneumococcique polyosidique, Pneumovax 23 oldatos injekció előretöltött fecskendőben Pneumococcus-poliszacharid vakcina, BOOSTRIX, suspension injectable en seringue préremplie Vaccin diphtérique, tétanique et coquelucheux (acellulaire multicomposé), (adsorbé, à teneur réduite en antigènes), Pneumovax 23 oldatos injekció e

    Novartis Pharmaceuticals

    Relapsing multiple sclerosis (RMS)

    phase 3 small molecule active

    1 trial

  10. Fluticasone Propionate

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  11. Fluticasone Propionate and Salmeterol Inhalation Powder

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  12. Fluticasone propionate

    Teva Pharma GmbH

    Seasonal Allergic Rhinitis

    phase 3 small molecule terminated

    1 trial

  13. Fluticasone propionate pressurized metered dose inhaler

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  14. Fluticasone propionate,Salbutamol sulfate, ProAir® RespiClick®, ProAir® Digihaler®, Fluticasone propionate,Salbutamol sulfate

    Lacuna Pharma Pty Ltd

    Asthma

    phase 3 small molecule active

    1 trial

  15. Follitropin alfa

    Ferring Pharmaceuticals

    Controlled Ovarian Simulation

    phase 3 small molecule completed

    1 trial

  16. Fosmanogepix, POSACONAZOLE , AMPHOTERICIN B , CASPOFUNGIN , ISAVUCONAZOLE , MICAFUNGIN , TERBINAFINE , VORICONAZOLE , ANIDULAFUNGIN , -, Fosmanogepix

    Lacuna Pharma Pty Ltd

    Invasive mold infections caused by Aspergillus spp., Fusarium spp., Lomentospora prolificans, Mucorales fungi, or other multidrug resistant molds

    phase 3 small molecule active

    1 trial

  17. Fostamatinib

    RIGEL PHARMACEUTICALS INC

    Covid19

    phase 3 small molecule completed

    1 trial

  18. Fostamatinib disodium

    RIGEL PHARMACEUTICALS INC

    Warm Antibody Autoimmune Hemolytic Anemia

    phase 3 small molecule active

    2 trials

  19. Fostamatinib disodium

    RIGEL PHARMACEUTICALS INC

    Immune Thrombocytopenic Purpura

    phase 3 small molecule completed

    3 trials

  20. Fp MDPI

    Teva Pharma GmbH

    Persistent Asthma

    phase 3 small molecule completed

    1 trial

  21. Fp/ABS

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule active

    1 trial

  22. Fremanezumab

    Teva Pharma GmbH

    Episodic Cluster Headache

    phase 3 small molecule terminated

    1 trial

  23. Fremanezumab

    Teva Pharma GmbH

    Migraine Prophylaxis

    phase 3 small molecule completed

    1 trial

  24. Fremanezumab

    Teva Pharma GmbH

    Chronic Cluster Headache

    phase 3 small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources